Manning Paul B 13D and 13G filings for Acumen Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:24 pm Sale | 2022-12-31 | 13G | Acumen Pharmaceuticals, Inc. ABOS | Manning Paul B | 3,205,128 7.800% | -805,550 (-20.09%) | Filing |
| 2022-02-14 7:27 pm Purchase | 2021-12-31 | 13G | Acumen Pharmaceuticals, Inc. ABOS | Manning Paul B | 4,010,678 9.900% | 4,010,678 (New Position) | Filing |